SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-21-000037
Filing Date
2021-10-28
Accepted
2021-10-28 16:42:58
Documents
83
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptct-20210930x10q.htm   iXBRL 10-Q 2524687
2 EX-31.1 ptct-20210930ex31148e50b.htm EX-31.1 10925
3 EX-31.2 ptct-20210930ex312cfafda.htm EX-31.2 10727
4 EX-32.1 ptct-20210930ex3212c752a.htm EX-32.1 5941
5 EX-32.2 ptct-20210930ex322663a01.htm EX-32.2 6127
  Complete submission text file 0001070081-21-000037.txt   11790884

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptct-20210930.xsd EX-101.SCH 70466
7 EX-101.CAL ptct-20210930_cal.xml EX-101.CAL 86768
8 EX-101.DEF ptct-20210930_def.xml EX-101.DEF 344874
9 EX-101.LAB ptct-20210930_lab.xml EX-101.LAB 719764
10 EX-101.PRE ptct-20210930_pre.xml EX-101.PRE 591579
11 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210930x10q_htm.xml XML 2462698
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 211358985
SIC: 2834 Pharmaceutical Preparations